FDA Approved: ASCLERA — Original Application (Methapharm, Inc)

View source ↗

Summary

FDA approves ASCLERA (polidocanol) for sclerotherapy to treat varicose veins and related superficial venous conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Telangiectasia
• Varicose Veins

Drugs mentioned

• ASCLERA (Polidocanol)

Snippet

ORIG AP for ASCLERA (POLIDOCANOL)